GlassScriptPhysician profile
Jehad E Saliba
NPI 1164480372
$25,134.02
in general payments reported to CMS, 2019-2025
73 companies · $4,278 in 2025
The $4,278 reported for 2025 was more than what 87% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,740 · 2020: $2,276 · 2021: $2,938 · 2022: $3,865 · 2023: $4,259 · 2024: $4,780 · 2025: $4,278.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Education: $220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,096.65 |
| Education | $219.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $5,417.66 | 2019-2025 | Fasenra, Farxiga, Breztri |
| Novo Nordisk INC | $2,517.95 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $2,089.20 | 2019-2025 | Nucala, Arexvy, Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,686.40 | 2019-2025 | Jardiance, Ofev, Jascayd |
| Amgen INC. | $1,422.17 | 2019-2025 | Tavneos, Otezla, Repatha |
| Lilly USA, LLC | $1,078.41 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Genzyme Corporation | $866.07 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $826.26 | 2019-2025 | Verquvo, Belsomra, Steglatro |
| Sanofi-Aventis U.S. LLC | $725.27 | 2019-2025 | |
| Pfizer INC. | $716.36 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $601.79 | 2021-2025 | Xifaxan, Trulance |
| Mallinckrodt Hospital Products INC. | $545.24 | 2020-2025 | Acthar |
| Ani Pharmaceuticals, INC. | $500.06 | 2022-2025 | Purified Cortrophin Gel |
| Astellas Pharma US INC | $416.64 | 2019-2025 | Veozah, Myrbetriq |
| Philips North America LLC | $391.50 | 2019-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
Show all 73 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $385.65 | 2022-2024 | Quviviq |
| Janssen Pharmaceuticals, INC | $299.43 | 2019-2024 | Xarelto |
| Kowa Pharmaceuticals America, INC. | $279.35 | 2019-2025 | Zoryve |
| Axsome Therapeutics, INC. | $268.45 | 2023-2025 | Sunosi, Auvelity |
| Takeda Pharmaceuticals U.S.A., INC. | $268.06 | 2019-2025 | Trintellix |
| Regeneron Healthcare Solutions, INC. | $260.60 | 2019-2025 | Dupixent |
| Jazz Pharmaceuticals INC. | $236.49 | 2019-2022 | |
| Intra-Sana Laboratories | $206.83 | 2024 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Scilex Pharmaceuticals INC. | $178.86 | 2021-2025 | |
| Mylan Specialty L.P. | $171.28 | 2019-2024 | Yupelri |
| Exact Sciences Corporation | $158.31 | 2023-2025 | Cologuard Collection Kit |
| Xeris Pharmaceuticals, INC. | $147.16 | 2023-2025 | Gvoke Hypopen |
| Allergan, INC. | $141.34 | 2019-2020 | |
| Almatica Pharma LLC | $138.68 | 2022-2025 | Loreev Xr, Gralise, Sertraline Hcl |
| Novartis Pharmaceuticals Corporation | $131.56 | 2021-2024 | |
| Amarin Pharma, INC. | $130.85 | 2019-2022 | |
| Nestle Healthcare Nutrition INC. | $117.18 | 2020-2023 | |
| Janssen Scientific Affairs, LLC | $112.31 | 2022 | |
| Baxter Healthcare | $107.47 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Monarch Airway Clearance System |
| Esperion Therapeutics, INC. | $102.70 | 2020-2024 | Nexletol |
| Abbvie INC. | $98.12 | 2021-2025 | |
| Lundbeck LLC | $90.68 | 2023-2025 | Rexulti |
| Sumitomo Pharma America, INC. | $80.32 | 2023-2025 | Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $77.49 | 2021-2024 | |
| E.R. Squibb & Sons, L.L.C. | $75.88 | 2019-2024 | Eliquis |
| Endo Pharmaceuticals INC. | $72.21 | 2019-2023 | Nascobal |
| Eisai INC. | $70.64 | 2020-2021 | |
| Harmony Biosciences LLC | $69.71 | 2024-2025 | |
| Otsuka America Pharmaceutical, INC. | $62.27 | 2023-2024 | Rexulti |
| Abbott Laboratories | $57.95 | 2019-2023 | Freestyle Libre 3 |
| Azurity Pharmaceuticals, INC. | $48.82 | 2023-2025 | Edarbi, Horizant |
| Teva Pharmaceuticals USA, INC. | $42.23 | 2020-2021 | |
| Sanofi Pasteur INC. | $42.08 | 2019-2020 | |
| Genentech USA, INC. | $39.40 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $39.15 | 2021 | |
| Sunovion Pharmaceuticals INC. | $37.47 | 2022 | |
| Althera Pharmaceuticals LLC | $35.67 | 2021-2022 | |
| Tolmar, INC. | $32.11 | 2023 | |
| Inogen, INC. | $31.84 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Urovant Sciences INC | $29.90 | 2021-2022 | |
| Paratek Pharmaceuticals, INC. | $29.72 | 2021-2023 | Nuzyra |
| Horizon Therapeutics Plc | $28.43 | 2019-2021 | |
| Amphastar Pharmaceuticals, INC. | $28.30 | 2024-2025 | |
| Mallinckrodt Enterprises LLC | $26.73 | 2019 | |
| Nabriva Therapeutics, Plc | $26.57 | 2020-2021 | |
| Grifols USA, LLC | $26.31 | 2019-2022 | |
| Pulmonx Corporation | $24.02 | 2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter |
| Ventec Life Systems, INC. | $20.36 | 2020 | |
| Averitas Pharma INC. | $18.52 | 2025 | Qutenza |
| Biotronik Nro, INC. | $17.96 | 2025 | Prospera |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $16.59 | 2025 | Caplyta |
| Biohaven Pharmaceutical Holding Company LTD. | $15.00 | 2022 | |
| Avanir Pharmaceuticals, INC. | $15.00 | 2019 | |
| Gilead Sciences, INC. | $14.40 | 2019 | |
| Seqirus USA INC | $14.26 | 2019 | |
| Eyevance Pharmaceuticals LLC | $11.63 | 2021 | |
| Hikma Pharmaceuticals USA | $11.63 | 2021 | |
| Nevro Corp. | $11.11 | 2021 |
Drugs and devices associated with these payments
Fasenra $1,759Dupixent $1,182Ozempic $962Rybelsus $745Jardiance $695Nucala $673Farxiga $665Arexvy $523Trelegy Ellipta $408Breztri $398Mounjaro $381Airsupra $377Xifaxan $363Quviviq $342Tezspire $338Purified Cortrophin Gel $331Acthar $290Ofev $286Symbicort $260Eliquis $247Verquvo $243Wegovy $242Glycate $207Reltone 400 Mg $207Reltone 200 Mg $207Tavneos $200Sunosi $183Trulance $159Cologuard Collection Kit $158Trintellix $158Lokelma $158Rexulti $153Gvoke Hypopen $147Repatha $109Otezla $109Loreev Xr $95.36Veozah $94.41Tzield $93.54Belsomra $90.58Auvelity $85.88Gemtesa $80.32Zepbound $70.49Paxlovid $69.75Wakix $69.71Ztlido $68.34Nurtec Odt $68.26Shingrix $65.93Yupelri $65.76Steglatro $59.49Entresto $58.80Leqvio $58.02(Ak6) Vest Therapy $51.13(8874) Incourage $49.81Vest Therapy Und $47.67Xarelto $36.50Zavzpret $35.02Edarbi $33.77Jatenzo $32.11Myrbetriq $31.88Inogen One G5 Oxygen Concentrator - Bluetooth $31.84Nexletol $31.22Kerendia $30.58Segluromet $30.01Soliqua 100/33 $29.06Zephyr Delivery Catheter $24.02Zephyr Endobronchial Valve $24.02Chartis Catheter $24.02Pulmonx Chartis Tablet Console $24.02Keytruda $22.22Freestyle Libre 3 $19.31Jascayd $18.87Qutenza $18.52Prospera $17.96Prevnar 20 $17.47Hillrom - Vest System Model 105 Home Care $17.04Caplyta $16.59Hillrom - Monarch Airway Clearance System $16.43Pneumovax 23 $15.94Vaxneuvance $15.94Evusheld $15.94Gardasil 9 $15.94Amyvid $15.49Nuzyra $15.20Horizant $15.05Flumist Quadrivalent $15.00Ubrelvy $14.87Benlysta $14.47Zenpep $14.09Zoryve $13.93Nascobal $13.77Gralise $13.67Sertraline Hcl $13.67Krystexxa $5.02
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jehad Saliba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.